Allene M. Diaz, Director at IONIS PHARMACEUTICALS INC (IONS), sold 2,854 shares at $42.53 ($121K) on 2025-08-22, disclosed to the SEC on 2025-08-26.
Scheduled sale ($121k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.53 | 1,427 | $61K | 50.0% |
| 2 | $42.53 | 1,427 | $61K | 50.0% |
| Total | $42.53 avg | 2,854 | $121K | 100% |
| Filing → |
| IONS | SELL | 2024-07-17 | $81K | — | Filing → |
| IONS | SELL | 2023-08-03 | $27K | — | Filing → |